2014 discharge: Innovative Medicines Initiative 2 Joint Undertaking (IMI2 Joint Undertaking)

2015/2200(DEC)

PURPOSE: to grant discharge to the IMI Joint Undertaking for the financial year 2014.

NON LEGISLATIVE ACT: Decision (EU) 2016/1591 of the European Parliament on discharge in respect of the implementation of the budget of the Joint Technology Initiative on Innovative Medicines for the financial year 2014.

CONTENT: with the present decision, the European Parliament grants discharge to the Executive Director of the Innovative Medicines Initiative 2 Joint Undertaking (formerly the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines) for the financial year 2014.

This decision is in line with the European Parliament's resolution adopted on 28 April 2016 and comprises a series of observations that form an integral part of the discharge decision (please refer to the summary of the opinion of 28 April 2016).

Amongst Parliament’s main observations in the resolution accompanying the discharge decision, the latter considered that, in the absence of a clear separation between FP 7 and Horizon 2020 implementation-related information, the indicators used do not ensure a real evaluation of performance.  It called on the Court to set out in its future reports information regarding the execution of the budget under FP 7 and that of Horizon 2020 separately.